Read: Whistleblower Complaint Claims Federal Response To COVID-19 Prioritized Politics Over Science
READ ON
BY CANDICE NORWOOD / PBS NewsHour
A former vaccine expert with the U.S. Department of Health and Human Services (HHS) alleges in a whistleblower complaint that he was ousted because his efforts to address the coronavirus pandemic conflicted with those of President Donald Trump and other administration officials.
In the complaint filed Tuesday, Dr. Rick Bright cites “his efforts to prioritize science and safety over political expediency” as reasons for his ousting. He also said he pushed to discuss the health risks of medicinal treatments promoted by Trump as possible cures for COVID-19.
Bright, the former director of the Biomedical Advanced Research and Development Authority, was demoted to a position with the National Institutes of Health late last month. The complaint asserts this move was “clearly a retaliatory demotion” and requests for Bright to be reinstated with HHS.
HHS spokeswoman Caitlin Oakley issued a statement refuting Bright’s characterization of his demotion and the department’s motivations, saying that he was transferred to a job with the National Institutes of Health to work on developing diagnostic testing for the coronavirus.
“We are deeply disappointed that he has not shown up to work on behalf of the American people and lead on this critical endeavor,” Oakley said.
Rep. Anna Eshoo, D-Calif., chairwoman of the House Energy and Commerce subcommittee on health, has said she will hold a hearing into Bright’s complaint next week.
Read the full text of Rick Bright’s whistleblower complaint here.
Copyright 2020 PBS NewsHour. To see more, visit pbs.org/newshour
Related Stories:
Whistleblower Alleges Fraud At A Large Medicare Advantage Plan In Seattle
As the Trump administration calls for expanding access to Medicare Advantage, a federal whistleblower lawsuit accuses a large Medicare Advantage plan of bilking Medicare out of $8 million.
Top Intelligence Official On Ukraine: ‘I Think The Whistleblower Did The Right Thing’
The acting director of national intelligence is meeting the House and Senate intelligence committees on Thursday as Washington roils over Ukraine and an ongoing impeachment inquiry.
